ORIC Pharmaceuticals (ORIC) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for ORIC Pharmaceuticals (ORIC).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 31M (+21.58%) | 26M (-10.11%) | 29M (-5.83%) | 31M (+23.99%) | 25M (-22.93%) | 32M (+2.47%) | 31M (+7.81%) | 29M (+31.79%) | 22M (-10.29%) | 24M (+9.33%) | 22M (+19.16%) | 19M (-3.74%) | 20M (+19.75%) | 16M (+10.73%) | 15M (+6.44%) | 14M (-17.83%) | 17M (+0.48%) | 17M (+29.84%) | 13M (-16.88%) | 16M (+32.65%) | 12M (-3.39%) | 12M (+37.15%) | 8.83M (+14.38%) | 7.72M (+6.48%) | 7.25M (+4.17%) | 6.96M (+23.62%) | 5.63M (+11.71%) | 5.04M (-3.26%) | 5.21M |
Selling General And Administrative | 8.18M (-5.98%) | 8.70M (+10.13%) | 7.90M (-7.28%) | 8.52M (+5.45%) | 8.08M (+6.32%) | 7.60M (+6.74%) | 7.12M (+0.56%) | 7.08M (+0.71%) | 7.03M (+1.15%) | 6.95M (+10.49%) | 6.29M (+1.29%) | 6.21M (+0.81%) | 6.16M (+5.84%) | 5.82M (-2.51%) | 5.97M (-12.97%) | 6.86M (+6.69%) | 6.43M (+6.11%) | 6.06M (+8.99%) | 5.56M (+0.36%) | 5.54M (+13.99%) | 4.86M (+13.02%) | 4.30M (+13.16%) | 3.80M (+11.76%) | 3.40M (+76.17%) | 1.93M (+6.63%) | 1.81M (+23.13%) | 1.47M (+11.36%) | 1.32M (+16.81%) | 1.13M |
Operating Expenses | 40M (+14.67%) | 35M (-5.78%) | 37M (-6.12%) | 39M (+19.38%) | 33M (-17.31%) | 40M (+3.26%) | 38M (+6.39%) | 36M (+24.25%) | 29M (-7.76%) | 31M (+9.59%) | 29M (+14.77%) | 25M (-2.69%) | 26M (+16.09%) | 22M (-13.90%) | 26M (+24.11%) | 21M (-11.01%) | 23M (+1.97%) | 23M (+23.56%) | 18M (-12.35%) | 21M (+27.25%) | 17M (-41.48%) | 28M (+10.47%) | 26M (+130.22%) | 11M (+21.13%) | 9.18M (+4.68%) | 8.77M (+23.52%) | 7.10M (+11.64%) | 6.36M (+0.16%) | 6.35M |
Depreciation And Amortization | 270K (-70.65%) | 920K | - | - | 300K (-64.71%) | 850K | - | - | 260K (-66.67%) | 780K | - | - | 250K (-65.28%) | 720K | - | - | 250K (-62.69%) | 670K | - | - | 230K (-68.06%) | 720K | - | - | 250K (-68.35%) | 790K | - | - | 240K |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -39.62M (+14.67%) | -34.55M (-5.78%) | -36.67M (-6.12%) | -39.06M (+19.38%) | -32.72M (-17.31%) | -39.57M (+3.26%) | -38.32M (+6.39%) | -36.02M (+24.25%) | -28.99M (-7.76%) | -31.43M (+9.59%) | -28.68M (+14.77%) | -24.99M (-2.69%) | -25.68M (+16.09%) | -22.12M (-13.90%) | -25.69M (+24.11%) | -20.70M (-11.01%) | -23.26M (+2.02%) | -22.80M (+23.51%) | -18.46M (-12.35%) | -21.06M (+27.25%) | -16.55M (-41.48%) | -28.28M (+10.47%) | -25.60M (+130.22%) | -11.12M (+21.13%) | -9.18M (+4.68%) | -8.77M (+23.52%) | -7.10M (+11.81%) | -6.35M (0.00%) | -6.35M |
Ebit | -39.62M (+14.67%) | -34.55M (-5.78%) | -36.67M (-6.12%) | -39.06M (+19.38%) | -32.72M (-17.31%) | -39.57M (+3.26%) | -38.32M (+6.39%) | -36.02M (+24.25%) | -28.99M (-7.76%) | -31.43M (+9.59%) | -28.68M (+14.77%) | -24.99M (-2.69%) | -25.68M (+16.09%) | -22.12M (-13.90%) | -25.69M (+24.11%) | -20.70M (-11.01%) | -23.26M (+2.02%) | -22.80M (+23.51%) | -18.46M (-12.35%) | -21.06M (+27.25%) | -16.55M (-41.48%) | -28.28M (+10.47%) | -25.60M (+130.22%) | -11.12M (+21.13%) | -9.18M (+4.68%) | -8.77M (+23.52%) | -7.10M (+11.81%) | -6.35M (0.00%) | -6.35M |
EBITDA | -39.35M (-2.67%) | -40.43M (+24.06%) | -32.59M (-10.34%) | -36.35M (+12.12%) | -32.42M (-30.32%) | -46.53M (+34.60%) | -34.57M (+8.17%) | -31.96M (+11.24%) | -28.73M (-19.97%) | -35.90M (+40.89%) | -25.48M (+11.07%) | -22.94M (-9.76%) | -25.42M (+12.08%) | -22.68M (-8.66%) | -24.83M (+22.38%) | -20.29M (-11.82%) | -23.01M (+3.60%) | -22.21M (+20.51%) | -18.43M (-12.28%) | -21.01M (+28.74%) | -16.32M (-41.10%) | -27.71M (+8.45%) | -25.55M (+131.85%) | -11.02M (+23.40%) | -8.93M (+0.11%) | -8.92M (+36.18%) | -6.55M (+9.90%) | -5.96M (-2.30%) | -6.10M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Other Non Operating Income | 3.85M (-71.57%) | 14M (+231.86%) | 4.08M (+50.55%) | 2.71M (+0.37%) | 2.70M (-82.06%) | 15M (+301.33%) | 3.75M (-7.41%) | 4.05M (+1.76%) | 3.98M (-60.52%) | 10M (+215.00%) | 3.20M (+56.10%) | 2.05M (+18.50%) | 1.73M (-34.72%) | 2.65M (+204.60%) | 870K (+112.20%) | 410K (+310.00%) | 100K (-37.50%) | 160K (+433.33%) | 30K (-40.00%) | 50K (+25.00%) | 40K (-91.67%) | 480K (+860.00%) | 50K (-50.00%) | 100K (-67.74%) | 310K (-81.66%) | 1.69M (+207.27%) | 550K (+41.03%) | 390K (+18.18%) | 330K |
Net Income | |||||||||||||||||||||||||||||
Net Income From Continuing Operations | -35.77M (+17.28%) | -30.50M (-6.41%) | -32.59M (-10.34%) | -36.35M (+21.09%) | -30.02M (-17.32%) | -36.31M (+5.03%) | -34.57M (+8.17%) | -31.96M (+27.79%) | -25.01M (-11.72%) | -28.33M (+11.19%) | -25.48M (+11.07%) | -22.94M (-4.18%) | -23.94M (+14.82%) | -20.85M (-16.03%) | -24.83M (+22.38%) | -20.29M (-12.39%) | -23.16M (+1.71%) | -22.77M (+23.55%) | -18.43M (-12.28%) | -21.01M (+27.26%) | -16.51M (-41.58%) | -28.26M (+10.61%) | -25.55M (+131.85%) | -11.02M (+24.24%) | -8.87M (+6.23%) | -8.35M (+27.48%) | -6.55M (+9.90%) | -5.96M (-0.83%) | -6.01M |
Net Income | -35.77M (+17.28%) | -30.50M (-6.41%) | -32.59M (-10.34%) | -36.35M (+21.09%) | -30.02M (-17.32%) | -36.31M (+5.03%) | -34.57M (+8.17%) | -31.96M (+27.79%) | -25.01M (-11.72%) | -28.33M (+11.19%) | -25.48M (+11.07%) | -22.94M (-4.18%) | -23.94M (+14.82%) | -20.85M (-16.03%) | -24.83M (+22.38%) | -20.29M (-12.39%) | -23.16M (+1.71%) | -22.77M (+23.55%) | -18.43M (-12.28%) | -21.01M (+27.26%) | -16.51M (-41.58%) | -28.26M (+10.61%) | -25.55M (+131.85%) | -11.02M (+24.24%) | -8.87M (+6.23%) | -8.35M (+27.48%) | -6.55M (+9.90%) | -5.96M (-0.83%) | -6.01M |
Comprehensive Income Net Of Tax | -36.84M (-71.46%) | -129.06M (+301.31%) | -32.16M (-11.60%) | -36.38M (+20.50%) | -30.19M (-76.36%) | -127.73M (+280.26%) | -33.59M (+4.77%) | -32.06M (+26.07%) | -25.43M (-74.35%) | -99.15M (+292.21%) | -25.28M (+9.87%) | -23.01M (-0.60%) | -23.15M (-74.37%) | -90.31M (+256.39%) | -25.34M (+22.30%) | -20.72M (-13.16%) | -23.86M (-69.72%) | -78.79M (+327.51%) | -18.43M (-12.32%) | -21.02M (+27.70%) | -16.46M (-77.68%) | -73.73M (+188.23%) | -25.58M (+132.12%) | -11.02M (+24.24%) | -8.87M (-67.00%) | -26.88M (+310.38%) | -6.55M | - | - |